Alain P. Gobert

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Mark J. Millan, Alain P. Gobert, F. Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 512 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

<i>Helicobacter pylori</i> arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival

Alain P. Gobert, David J. McGee, Mahmood Akhtar et al. · Proceedings of the National Academy of Sciences · 2001 · 374 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

Alain P. Gobert, Jean‐Michel Rivet, Adrian Newman‐Tancredi et al. · Synapse · 2000 · 336 citations

Medicine, Neuroscience, Pharmacology +17

(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

Robert D. Schreiber, Mauricette Brocco, Valérie Audinot et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 295 citations

Medicine, Neuroscience, Pharmacology +17

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

Mark J. Millan, Anne Dekeyne, Alain P. Gobert · Neuropharmacology · 1998 · 283 citations

Life Sciences, Neuroscience, Pharmacology +12